BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao Y, Li X, Zeng C, Liu C, Hao Q, Li W, Zhang K, Zhang W, Wang S, Zhao H, Fan D, Li M, Zhang Y, Zhang W, Zhang C. CD63+ Cancer-Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR-22. Adv Sci (Weinh) 2020;7:2002518. [PMID: 33173749 DOI: 10.1002/advs.202002518] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Yi X, Huang D, Li Z, Wang X, Yang T, Zhao M, Wu J, Zhong T. The role and application of small extracellular vesicles in breast cancer. Front Oncol 2022;12:980404. [DOI: 10.3389/fonc.2022.980404] [Reference Citation Analysis]
2 Wu C, Gu J, Gu H, Zhang X, Zhang X, Ji R. The recent advances of cancer associated fibroblasts in cancer progression and therapy. Front Oncol 2022;12:1008843. [DOI: 10.3389/fonc.2022.1008843] [Reference Citation Analysis]
3 Shi Y, Ding W, Gu W, Shen Y, Li H, Zheng Z, Zheng X, Liu Y, Ling Y. Single-cell phenotypic profiling to identify a set of immune cell protein biomarkers for relapsed and refractory diffuse large B cell lymphoma: A single-center study. J Leukoc Biol 2022. [PMID: 36040107 DOI: 10.1002/JLB.6MA0822-720RR] [Reference Citation Analysis]
4 Zhang Y, Xing Z, Liu T, Tang M, Mi L, Zhu J, Wu W, Wei T. Targeted therapy and drug resistance in thyroid cancer. European Journal of Medicinal Chemistry 2022;238:114500. [DOI: 10.1016/j.ejmech.2022.114500] [Reference Citation Analysis]
5 Gu Y, Wang W, Li Y, Li H, Guo Z, Wei C, Long M, Chung M, Aimaier R, Li Q, Wang Z. Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response. Front Oncol 2022;12:903177. [DOI: 10.3389/fonc.2022.903177] [Reference Citation Analysis]
6 Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer 2022;3:793-807. [PMID: 35883004 DOI: 10.1038/s43018-022-00411-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li X, Yu Q, Zhao R, Guo X, Liu C, Zhang K, Zhang W, Liu J, Yu J, Wang S, Hao Q, Li W, Zhang W, Li M, Zhang Y, Zhang C, Gao Y. Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma. Front Oncol 2022;12:898156. [DOI: 10.3389/fonc.2022.898156] [Reference Citation Analysis]
8 Ashrafizadeh M, Zarrabi A, Mostafavi E, Aref AR, Sethi G, Wang L, Tergaonkar V. Non-coding RNA-based regulation of inflammation. Semin Immunol 2022;:101606. [PMID: 35691882 DOI: 10.1016/j.smim.2022.101606] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Khan MI, Alsayed RKME, Choudhry H, Ahmad A. Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery. Int J Mol Sci 2022;23:6222. [PMID: 35682901 DOI: 10.3390/ijms23116222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Tang J, He J, Feng C, Tu C. Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions. Front Pharmacol 2022;13:902049. [PMID: 35592419 DOI: 10.3389/fphar.2022.902049] [Reference Citation Analysis]
11 Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, Zhuo W, Hu Y, Chen C, Chen L, Zhou J, Wang L. Cancer-associated fibroblasts in breast cancer: Challenges and opportunities. Cancer Commun (Lond) 2022. [PMID: 35481621 DOI: 10.1002/cac2.12291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 De P, Aske J, Sulaiman R, Dey N. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance. Cancers 2022;14:1519. [DOI: 10.3390/cancers14061519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kumar DN, Chaudhuri A, Aqil F, Dehari D, Munagala R, Singh S, Gupta RC, Agrawal AK. Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application. Cancers 2022;14:1435. [DOI: 10.3390/cancers14061435] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
14 Wang H, Wang D, Luo B, Wang D, Jia H, Peng P, Shang Q, Mao J, Gao C, Peng Y, Gan L, Du J, Luo Z, Yang L. Decoding the annulus fibrosus cell atlas by scRNA-seq to develop an inducible composite hydrogel: A novel strategy for disc reconstruction. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.01.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Hosseini K, Ranjbar M, Pirpour Tazehkand A, Asgharian P, Montazersaheb S, Tarhriz V, Ghasemnejad T. Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing. J Transl Med 2022;20:30. [PMID: 35033106 DOI: 10.1186/s12967-022-03231-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Samuels M, Cilibrasi C, Papanastasopoulos P, Giamas G. Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment. Biomolecules 2022;12:132. [DOI: 10.3390/biom12010132] [Reference Citation Analysis]
17 Villegas-Pineda JC, Lizarazo-Taborda MDR, Ramírez-de-Arellano A, Pereira-Suárez AL. Exosomal miRNAs and lncRNAs: The Modulator Keys of Cancer-Associated Fibroblasts in the Genesis and Progression of Malignant Neoplasms. Front Cell Dev Biol 2021;9:717478. [PMID: 34912797 DOI: 10.3389/fcell.2021.717478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Nakase I, Takatani-Nakase T. Exosomes: Breast cancer-derived extracellular vesicles; recent key findings and technologies in disease progression, diagnostics, and cancer targeting. Drug Metab Pharmacokinet 2021;42:100435. [PMID: 34922046 DOI: 10.1016/j.dmpk.2021.100435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li C, Teixeira AF, Zhu HJ, Ten Dijke P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer 2021;20:154. [PMID: 34852849 DOI: 10.1186/s12943-021-01463-y] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
20 Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
21 Mu J, Gao S, Yang J, Wu F, Zhou H. Fundamental and Clinical Applications of Materials Based on Cancer-Associated Fibroblasts in Cancers. Int J Mol Sci 2021;22:11671. [PMID: 34769102 DOI: 10.3390/ijms222111671] [Reference Citation Analysis]
22 De P, Aske J, Dey N. Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy. Cancers (Basel) 2021;13:5246. [PMID: 34680395 DOI: 10.3390/cancers13205246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Alhusban AA, Albustanji S, Hamadneh LA, Shallan AI. High Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Correlating the Metabolic Changes of Lactate, Pyruvate and L-Glutamine with Induced Tamoxifen Resistant MCF-7 Cell Line Potential Molecular Changes. Molecules 2021;26:4824. [PMID: 34443413 DOI: 10.3390/molecules26164824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Cosentino G, Plantamura I, Tagliabue E, Iorio MV, Cataldo A. Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay. Cancers (Basel) 2021;13:3691. [PMID: 34359591 DOI: 10.3390/cancers13153691] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Liu C, Han J, Li X, Huang T, Gao Y, Wang B, Zhang K, Wang S, Zhang W, Li W, Hao Q, Li M, Zhang Y, Zhang C. FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1. Front Oncol 2021;11:656190. [PMID: 34307133 DOI: 10.3389/fonc.2021.656190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Fernández-Nogueira P, Fuster G, Gutierrez-Uzquiza Á, Gascón P, Carbó N, Bragado P. Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis. Cancers (Basel) 2021;13:3146. [PMID: 34201840 DOI: 10.3390/cancers13133146] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
27 Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, Deng S, Zhou H. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther 2021;6:218. [PMID: 34108441 DOI: 10.1038/s41392-021-00641-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 41] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang Z, Liu J, Huang H, Ye M, Li X, Wu R, Liu H, Song Y. Metastasis-associated fibroblasts: an emerging target for metastatic cancer. Biomark Res 2021;9:47. [PMID: 34112258 DOI: 10.1186/s40364-021-00305-9] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
29 Wang T, Jin J, Qian C, Lou J, Lin J, Xu A, Xia K, Jin L, Liu B, Tao H, Yang Z, Yu W. Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment. Cancer Cell Int 2021;21:295. [PMID: 34098945 DOI: 10.1186/s12935-021-02003-w] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
30 Sun G, Li Z, Rong D, Zhang H, Shi X, Yang W, Zheng W, Sun G, Wu F, Cao H, Tang W, Sun Y. Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges. Mol Ther Oncolytics 2021;21:183-206. [PMID: 34027052 DOI: 10.1016/j.omto.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Gao Y, Qin Y, Wan C, Sun Y, Meng J, Huang J, Hu Y, Jin H, Yang K. Small Extracellular Vesicles: A Novel Avenue for Cancer Management. Front Oncol 2021;11:638357. [PMID: 33791224 DOI: 10.3389/fonc.2021.638357] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
32 Mehdizadehtapeh L, Obakan Yerlİkaya P. Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors. Turk J Biol 2021;45:1-16. [PMID: 33597817 DOI: 10.3906/biy-2010-62] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Abadi AJ, Zarrabi A, Gholami MH, Mirzaei S, Hashemi F, Zabolian A, Entezari M, Hushmandi K, Ashrafizadeh M, Khan H, Kumar AP. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules 2021;11:304. [PMID: 33670518 DOI: 10.3390/biom11020304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]